Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause-Specific Mortality Risk in Rheumatoid Arthritis
- PMID: 31811708
- PMCID: PMC7275877
- DOI: 10.1002/acr.24120
Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause-Specific Mortality Risk in Rheumatoid Arthritis
Abstract
Objective: To elucidate how postdiagnosis multimorbidity and lifestyle changes contribute to the excess mortality of rheumatoid arthritis (RA).
Methods: We performed a matched cohort study among women in the Nurses' Health Study (1976-2018). We identified women with incident RA and matched each by age and year to 10 non-RA comparators at the RA diagnosis index date. Specific causes of death were ascertained via death certificates and medical record review. Lifestyle and morbidity factors were reported biennially; 61 chronic conditions were combined into the Multimorbidity Weighted Index (MWI). After adjusting for baseline confounders, we used inverse probability weighting analysis to examine the mediating influence of postindex MWI scores and lifestyle factors on total, cardiovascular, and respiratory mortality, comparing women with RA to their matched comparators.
Results: We identified 1,007 patients with incident RA and matched them to 10,070 non-RA comparators. After adjusting for preindex confounders, we found that hazard ratios (HRs) and 95% confidence intervals (95% CIs) were higher for total mortality (HR 1.46 [95% CI 1.32, 1.62]), as well as cardiovascular (HR 1.54 [95% CI 1.22, 1.94]) and respiratory (HR 2.75 [95% CI 2.05, 3.71]) mortality in patients with RA compared to non-RA comparators. Adjusting for postindex lifestyle factors (physical activity, body mass index, diet, smoking) attenuated but did not substantially account for this excess RA mortality. After additional adjustment for postindex MWI scores, patients with RA had HRs of 1.18 (95% CI 1.05, 1.32) for total, 1.19 (95% CI 0.94, 1.51) for cardiovascular, and 1.93 (95% CI 1.42, 2.62) for respiratory mortality.
Conclusion: We found that MWI scores substantially accounted for the excess total and cardiovascular mortality among women with RA. This finding underscores the importance of monitoring for the total disease burden as a whole in monitoring patients with RA.
© 2019, American College of Rheumatology.
Figures
References
-
- Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–1307. - PubMed
-
- Mellemkjaer L, Linet MS, Gridley G, Frisch M, Møller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A:1753–1757. - PubMed
-
- Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287–2293. - PubMed
-
- Gabriel SE, Crowson CS, O’Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529–2533. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AR069625/AR/NIAMS NIH HHS/United States
- R01 AR071326/AR/NIAMS NIH HHS/United States
- P30 AR072577/AR/NIAMS NIH HHS/United States
- P30 AR070253/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- K23 AR069688/AR/NIAMS NIH HHS/United States
- K23 AG056638/AG/NIA NIH HHS/United States
- R03 AR075886/AR/NIAMS NIH HHS/United States
- U01 HG008685/HG/NHGRI NIH HHS/United States
- K23 AR076453/AR/NIAMS NIH HHS/United States
- R01 AR057327/AR/NIAMS NIH HHS/United States
- U01 CA176726/CA/NCI NIH HHS/United States
- L30 AR066953/AR/NIAMS NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
